{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:22:24Z","timestamp":1774362144073,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"9719","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/s0140-6736(10)60232-2","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T04:31:00Z","timestamp":1267245060000},"page":"1014-1028","source":"Crossref","is-referenced-by-count":584,"title":["HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage"],"prefix":"10.1016","volume":"375","author":[{"given":"Bradley M","family":"Mathers","sequence":"first","affiliation":[]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[]},{"given":"Hammad","family":"Ali","sequence":"additional","affiliation":[]},{"given":"Lucas","family":"Wiessing","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[]},{"given":"Richard P","family":"Mattick","sequence":"additional","affiliation":[]},{"given":"Bronwyn","family":"Myers","sequence":"additional","affiliation":[]},{"given":"Atul","family":"Ambekar","sequence":"additional","affiliation":[]},{"given":"Steffanie A","family":"Strathdee","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(10)60232-2_bib1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)60232-2_bib3","series-title":"Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors","first-page":"1109","article-title":"Illicit drug use","author":"Degenhardt","year":"2004"},{"key":"10.1016\/S0140-6736(10)60232-2_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2007.03.014","article-title":"Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge","volume":"90","author":"Rachlis","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S0140-6736(10)60232-2_bib5","author":"Tilson"},{"key":"10.1016\/S0140-6736(10)60232-2_bib6","unstructured":"Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and HIV transmission among injecting drug users: a review of reviews. Addiction (in press)."},{"key":"10.1016\/S0140-6736(10)60232-2_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004145.pub3","article-title":"Substitution treatment of injecting opioid users for prevention of HIV infection","volume":"2","author":"Gowing","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S0140-6736(10)60232-2_bib8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/S0140-6736(10)60232-2_bib10","author":"Cook"},{"key":"10.1016\/S0140-6736(10)60232-2_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2105\/AJPH.2008.141846","article-title":"Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users","volume":"99","author":"Wiessing","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/S0140-6736(10)60232-2_bib12","author":"Calabria"},{"key":"10.1016\/S0140-6736(10)60232-2_bib14","unstructured":"WHO. Global health ATLAS data 2009 (in press)."},{"key":"10.1016\/S0140-6736(10)60232-2_bib15","unstructured":"Ministry of Health of the Republic of Uzbekistan. Letter to the Office of the United Nations Development Programme in the Republic of Uzbekistan. June 15, 2009. Tashkent, 2009."},{"issue":"suppl","key":"10.1016\/S0140-6736(10)60232-2_bib17","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.drugpo.2007.11.008","article-title":"Access to syringes in three Russian cities: Implications for syringe distribution and coverage","volume":"19","author":"Sarang","year":"2008","journal-title":"Int J Drug Policy"},{"key":"10.1016\/S0140-6736(10)60232-2_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.qai.0000219788.73539.47","article-title":"Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users","volume":"42","author":"Vickerman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S0140-6736(10)60232-2_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/QAI.0b013e31819906f3","article-title":"Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan","volume":"51","author":"Emmanuel","year":"2009","journal-title":"J Acquir Immune Defici Syndr"},{"key":"10.1016\/S0140-6736(10)60232-2_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(02)00346-8","article-title":"Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?","volume":"2","author":"Velasco-Hernandez","year":"2002","journal-title":"Lancet Infect Dis"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673610602322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673610602322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T18:24:11Z","timestamp":1544639051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673610602322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":16,"journal-issue":{"issue":"9719","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0140673610602322"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(10)60232-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}